Elicio Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $-74.5M | $88.8M |
| FY2022 | — | $-102.1M | $6.2M |
| FY2023 | — | $11.4M | $12.9M |
| FY2024 | $20.0M | $-11.3M | $17.6M |
| FY2025 | $9.4M | $1.6M | $18.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $-74.5M | $88.8M |
| FY2022 | — | $-102.1M | $6.2M |
| FY2023 | — | $11.4M | $12.9M |
| FY2024 | $20.0M | $-11.3M | $17.6M |
| FY2025 | $9.4M | $1.6M | $18.6M |